![moca testing scores vs mmse scores moca testing scores vs mmse scores](http://article.sapub.org/image/10.5923.j.ijbcs.20190801.01_009.gif)
Results: From the total number of patients (n=31), 6/31 (19.4%) were males and 25/30 (80.6%) were females mean duration of illness was 9,86☘,22 years mean total PANSS score was 99,20☒2,48 mean MoCA score was 17,54±4,80 (>24 normal) and mean MMSE score was 23,48☓,65(>26 normal).There was a significant difference between these two screening tools in terms of measurement of cognitive impairment (X²=20.16, p=0,001).Ĭonclusions: Our preliminary findings may suggest that MoCA scale performs well in detecting mild and moderate cognitive impairments of schizophrenia patients compared to MMSE. Neither test is designed to differentiate between the cause of a cognitive impairment. However you can use either test consistently to track progress over time. However, MMSE and MOCA scores are not interchangeable. It also gives a score on a 30-point scale, like MMSE. For the assessment of cognitive impairment, we used Montreal Cognitive Assessment Scale (MoCA) and Mini-Mental State Examination (MMSE). It is slightly more ‘interesting’ test to perform as a doctor. Patients were selected from Psychiatric Clinic, Erenkoy Research and Training Hospital for Psychiatric and Neurological Disorders (ERSHEAH) in the period between March 2013 and June 2013. Methods: This clinical study included 31 patients with diagnosed schizophrenia. The aim of this study was to assess the clinical usability of the Montreal Cognitive Assessment (MoCA) as a screening instrument for cognitive impairment in schizophrenic patients alone, and in correlation with the Mini-Mental State Examination (MMSE). Cognitive impairment is related to clinical symptoms, social and functional outcome. Objective: Schizophrenia is a complex neurodevelopmental disorder and the cognitive deficit is the central feature of schizophrenia.